AKT1 and melanoma: QA enhances the therapeutic response to PD1(L1) in colon cancer (Lin et al., 2018), and which also inhibits p-PI3K and p-AKT expression and suppresses the proliferation and growth of melanoma cells (Kang et al., 2021).